An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia

Investigative Radiology

Volumn 31, Issue 9, 1996, Pages 550-555

  La Noce, Anna ^a   Miragoli, Luigi ^a   Samuelli, Giovanni ^a   Tirone, Piero ^a  

^a Bracco SpA   (Italy)

Author keywords

brain ischemia; Gadobenate dimeglumine; neurotolerability; visual evoked potentials

Indexed keywords

EVANS BLUE; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL; ROSE BENGAL; SODIUM CHLORIDE;

ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EVOKED VISUAL RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

EID: 0029763082     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199609000-00002     Document Type: Article

References (15)

1. Scotti G, Dalla Palma L, Scialfa G, et al. Gadobenate dimeglumine in MR imaging of intracranial tumors. In: Salvolini U, Leonardi M, eds. Neuroradiologia 1993. Udine: Edizione del Centauro, 1993.
2. Crain MR, Yuh WTC, Greene GM, et al. Cerebral ischemia: Evaluation with contrast-enhanced MR imaging. Am J Neuroradiol 1991;12:631-639.
3. Lo EH, Pan Y, Matsumoto K, Kowall NW. Blood-brain barrier disruption in experimental focal ischemia: Comparison between in vivo MRI and immunocytochemistry. Magn Reson Imaging 1994;12:403-411.
4. Corsico N, Tirone P. Neurophysiological assessment of neural tolerance of a new paramagnetic complex. In: Nadjmi M, ed. Proceedings of the 15th Congress of the European Society of Neuroradiology. Berlin: Springer-Verlag, 1988.
5. Groome JJ, Gojowczyk G, Hofman W, Graham DI. Quantitation of photochemically induced of focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1988;8:89-95.
6. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985;17:497-504.
7. Broadbridge AT, Bayliss SG, Brayshaw CI. The effect of intrathecal iohexol on visual evoked response latency: A comparison including incidence of headhache with iopamidol and metrizamide in myeloradiculography. Clin Radiol 1987;38:71-74.
8. Caillé JM, Gioux M, Arné P, Paty J. Neurotoxicity of nonionic iodinated water-soluble CM in myelography: Experimental study. AJNR Am J Neuroradiol 1983;4:1185-1189.
9. Mattsson JL, Albee RR. Sensory evoked potentials in neurotoxicology. Neurotoxicol Teratol 1988;10:435-443.
10. Rebert CS. Multisensory evoked potentials in experimental and applied neurotoxicology. Neurobehav Toxicol Teratol 1983;5: 659-671.
11. Onofrj M, Bodis-Wollner I. Dopaminergic deficiency causes delayed visual evoked potentials in rats. Ann Neurol 1982;11: 484-490.
12. Dyer RS, Jensen KF, Boyes WK. Focal lesions of visual cortex: Effects of visual evoked potentials in rats. Exp Neurol 1987;95: 100-115.
13. Dyer RS, Clark CC, Boyes WK. Surface distribution of flash-evoked and pattern reversal-evoked potentials in hooded rats. Brain Res Bull 1987;18:227-234.
14. Forsting M, Reith W, Dorfler A, Meyding-Lamadé U, Sartor K. MRI monitoring of experimental cerebral ischemia: Comparison of two models. Neuroradiol 1994;36:264-268.
15. Van de Vyver FL, Persman GV. Experimental cerebral infarction in the rat: Utility of Gd-DOTA for MR imaging. Magn Res Imag 1990;8:333-340.